0.9243USD+5.17%Mkt Cap: 4.54M $P/E: —2d ago
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal He…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap4.54M $
Enterprise Value35.49M $
Revenue (TTM)29.57M $
Gross Profit7.74M $
Net Income (TTM)-53.43M $
Revenue/Share154.72 USD
Last Price0.9243 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees47
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.15
PEG—
EV/EBITDA-1.50
EV/Revenue1.20
P/S0.15
P/B-0.01
EPS (TTM)-654.39
EPS (Forward)-5.68
52W Range
0.72510% of range85.40
52W High85.40 USD
52W Low0.7251 USD
Profitability
Gross Margin67.21%
Oper. Margin50.23%
EBITDA Margin-79.81%
Profit Margin-464.20%
ROE309.06%
ROA-139.43%
Growth
Revenue Growth815.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.69M $
CapEx (TTM)41.00K $
FCF Margin-7.05%
FCF Yield-45.95%
Net Debt27.03M $
Net Debt/EBITDA-1.15
Balance Sheet
Debt/Equity-2.52
Current Ratio0.65
Quick Ratio0.24
Book Value/Sh-99.2020 USD
Cash/Share12.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 7, 2019
Splits
Last Split1:35
Split DateApr 30, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.91M
Float541.76K
Insiders8.16%
Institutions0.10%
Short Interest
Short Ratio1.1d
Short % Float1.77%
Short % Out.1.77%
Shares Short87.15K
Short (prev mo.)73.83K
Technical
SMA 501.762 (-47.6%)
SMA 20019.05 (-95.1%)
Beta-0.05
S&P 52W Chg18.16%
Avg Vol (30d)135.47K
Avg Vol (10d)256.26K
Technical Indicators
RSI (14)33.1
MACD-0.3168
MACD Signal-0.3915
MACD Hist.+0.0748
BB Upper1.204 USD
BB Middle0.9559 USD
BB Lower0.7080 USD
BB Width51.87%
ATR (14)0.1540 USD
Vol Ratio (20d)1.44x